Co-operative Pharmacy breaks into secondary care with Doncaster outpatient dispensing contract

Multiples The Co-operative Pharmacy is moving into secondary care, after being awarded a seven-year outpatient dispensing contract with Doncaster and...
Forgotten your password?
The page you are looking for is only available to logged in members of Chemist+Druggist.
Not a member yet?
Register now
If you are not a registered user, then please sign up here. Registering is free and takes just seconds. It gives you access to up-to-the minute news alerts and analysis, all our top bloggers.
If you experience any difficulties logging in or registering, or have any other questions, please contact Chemist+Druggist at haveyoursay@chemistanddruggist.co.uk
Comment on this article
You are not currently logged in. Login or register
Your Comments
A Pothecary, Community pharmacist
Posted on 20 September 2011.
I am interested to hear that the Co-op are committed to delivering a patient-focused service in the new hospital setting.

Once again it seems Doncaster is a the forefront of innovation in pharmacy as it was with its Pharmacy Quality Outcomes Framework.

It would be very interesting to see if the QOF results could be obtained under a freedom of information request, and a correlation between quality of pharmacy services in the community and the award of such an important contract was evident.

I always thought that the QOF could be used as a benchmark for future services, as it would make sense to want to work with and engage with quality pharmacies within the community network.

It is a pity that the QOF has now ceased, but never the less, the result would make interesting reading.
Top
David Miller, Hospital pharmacist
Posted on 20 September 2011.
I would be more interested in a FOI on whether a in-house bid was considered and if not why not. There is clear Traesury guidance that any scheme that is undertaken for tax avoidance in this case VAT is not allowed. So the focus and rhetoric will be on patient benefits like reduced waiting times and improved inpatient care, but who pockets the 20% VAT now ?

Are the costs with this tax excluded lower or higher and if higher it means you and I the individual taxpayer have lost out again to the corporate pharmacy agenda.
Top

Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments. However, any comments deemed to be libellous will be removed

Job of the week

Commercial Services Manager

Runcorn, Cheshire
£competitive

Follow C+D Jobs on

 
Should pharmacists be involved in the MMR catch-up programme?